Pith. sign in

REVIEW 6 cited by

Conditional Antibody Design as 3D Equivariant Graph Translation

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 2208.06073 v6 pith:FGSUQPDQ submitted 2022-08-12 q-bio.BM cs.LG

classification q-bio.BMcs.LG
keywords designantibodyequivariantmeansequencesstructureaffinityantigen-binding
verification ladder T0 review T1 audit T2 compute T3 formal

Signed reviews

No signed human review yet.

0 comments
read the original abstract

Antibody design is valuable for therapeutic usage and biological research. Existing deep-learning-based methods encounter several key issues: 1) incomplete context for Complementarity-Determining Regions (CDRs) generation; 2) incapability of capturing the entire 3D geometry of the input structure; 3) inefficient prediction of the CDR sequences in an autoregressive manner. In this paper, we propose Multi-channel Equivariant Attention Network (MEAN) to co-design 1D sequences and 3D structures of CDRs. To be specific, MEAN formulates antibody design as a conditional graph translation problem by importing extra components including the target antigen and the light chain of the antibody. Then, MEAN resorts to E(3)-equivariant message passing along with a proposed attention mechanism to better capture the geometrical correlation between different components. Finally, it outputs both the 1D sequences and 3D structure via a multi-round progressive full-shot scheme, which enjoys more efficiency and precision against previous autoregressive approaches. Our method significantly surpasses state-of-the-art models in sequence and structure modeling, antigen-binding CDR design, and binding affinity optimization. Specifically, the relative improvement to baselines is about 23% in antigen-binding CDR design and 34% for affinity optimization.

Discussion (0). Continue with ORCID to comment.

Forward citations

Cited by 6 Pith papers

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score. Full citation record

  1. Attribution assignment for deep-generative sequence models enables interpretability analysis using positive-only data

    cs.LG 2025-06 conditional novelty 6.0 of 10

    A new attribution metric for autoregressive generative sequence models, GAMA, recovers implanted motifs in synthetic data and partially identifies known antibody binding positions.

  2. AbFlowNet: Optimizing Antibody-Antigen Binding Energy via Diffusion-GFlowNet Fusion

    cs.LG 2025-05 conditional novelty 6.0 of 10

    AbFlowNet trains a diffusion-based antibody CDR designer with a GFlowNet Trajectory Balance term so that sampled CDRs are rewarded for lower Rosetta-estimated binding energy, improving energy and reconstruction metric...

  3. A Simple yet Effective DDG Predictor is An Unsupervised Antibody Optimizer and Explainer

    q-bio.QM 2025-02 reject novelty 6.0 of 10

    Light-DDG is a fast, distilled Transformer for binding-energy mutation prediction that is repurposed as an antibody optimizer and explainer, but its benchmark gains may be inflated by training on teacher-generated mut...

  4. Relation-Aware Equivariant Graph Networks for Epitope-Unknown Antibody Design and Specificity Optimization

    q-bio.QM 2024-12 conditional novelty 6.0 of 10

    RAAD is a relation-aware equivariant graph network that co-generates antibody CDR sequences and structures in one shot and adds a contrastive specificity loss.

  5. Hotspot-Driven Peptide Design via Multi-Fragment Autoregressive Extension

    q-bio.BM 2024-11 conditional novelty 6.0 of 10

    PepHAR generates peptide binders by first sampling hot-spot residues from a learned energy model, then autoregressively extending fragments via dihedral angles, then refining the full structure.

  6. Antibody Design and Optimization with Multi-scale Equivariant Graph Diffusion Models for Accurate Complex Antigen Binding

    cs.LG 2025-06 conditional novelty 5.0 of 10

    AbMEGD, a fusion of ViS-MP and IPA inside a diffusion process, reports modest CDR-H3 gains over DiffAb on SAbDab.

Pith tools